ANGO

AngioDynamics, Inc.
Data: 2026-05-15
$10.77
Price
-2.36%
Change
$13.91
52W High
$8.36
52W Low

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Quick Stats
May 15, 2026

60.6

AI Score

BUY

0.59

Volume Ratio

Apr 02, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

ANGO Stock Summary

Last updated May 15, 2026

ANGO is currently trading at $10.77, positioned below its 200-day moving average of $11.1, suggesting bearish momentum. The stock has a 52-week range of $8.36 to $13.91.

Technical Analysis: The 50-day moving average stands at $10.77, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.022, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.143, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ANGO at 60.6/100 with a BUY recommendation.

ANGO (AngioDynamics, Inc.) Indicators

Last updated May 15, 2026

Indicator Value
RSI(14) 48.022
CMF (20) -0.143
ROC (10) -3.495
ADX (14) 15.886
Indicator Value
MACD (12,26,9) 0.047
AROONOSC (14) 50.0
WILLAMS %R (14) -70.455
MFI (14) 29.538
ANGO Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ANGO Price vs Max Options Open Interest
ANGO Max Change In Options Open Interest

ANGO Options - Sort by Max open Interest (near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANGO Daily Out of Money Options - Sort by Max open Interest (near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANGO Daily In the Money Options - Sort by Max open Interest (near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANGO Most Active Options by Volume(near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

AngioDynamics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ANGO Moving Averages Analysis

ANGO (AngioDynamics, Inc.) Simple Moving Averages

Moving Averages are last updated May 15, 2026

Days MA
10 10.98
20 10.98
30 10.72
50 10.77
100 10.97
200 11.1

ANGO Fundamental Analysis

P/E (Forward) 96.1538
P/E (Trailing) --
Market Cap ($) 455.7 million
Earnings/Share ($) -0.76
Net Proft Margin (%) -0.1001
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.2033
EPS Estimate Next Year ($) -0.22
WallStreet Target Price ($) 18
Most Recent Quarter